InorbitTX visit to Swiss Nordic Bio 2022

100K kr SEK

Funder	Vinnova
Recipient Organization	Inorbit Therapeutics Ab
Country	Sweden
Start Date	Dec 04, 2021
End Date	Jan 26, 2022
Duration	53 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	Swedish Research Council
Grant ID	`2021-04960_Vinnova`

Grant Description

Purpose and goal: InOrbitTX was presented and potential investors and alliance partners were met. Expected results and effects: We hope that one or more of the new contacts will invest in InOrbitTX. Approach and implementation: ???